» Articles » PMID: 26042632

Institutional Review Boards: Purpose and Challenges

Overview
Journal Chest
Publisher Elsevier
Specialty Pulmonary Medicine
Date 2015 Jun 5
PMID 26042632
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Institutional review boards (IRBs) or research ethics committees provide a core protection for human research participants through advance and periodic independent review of the ethical acceptability of proposals for human research. IRBs were codified in US regulation just over three decades ago and are widely required by law or regulation in jurisdictions globally. Since the inception of IRBs, the research landscape has grown and evolved, as has the system of IRB review and oversight. Evidence of inconsistencies in IRB review and in application of federal regulations has fueled dissatisfaction with the IRB system. Some complain that IRB review is time-consuming and burdensome without clear evidence of effectiveness at protecting human subjects. Multiple proposals have been offered to reform or update the current IRB system, and many alternative models are currently being tried. Current focus on centralizing and sharing reviews requires more attention and evidence. Proposed changes to the US federal regulations may bring more changes. Data and resourcefulness are needed to further develop and test review and oversight models that provide adequate and respectful protections of participant rights and welfare and that are appropriate, efficient, and adaptable for current and future research.

Citing Articles

Ethics Committees' Practices in Healthcare, Banking and Research: Key Requirements for Their Functionality.

Arik T, Michl S J Eval Clin Pract. 2025; 31(1):e14310.

PMID: 39868441 PMC: 11771612. DOI: 10.1111/jep.14310.


Going paperless: the strengths and limitations of electronic research ethics information management system in a health training institution in Tanzania.

Mkumbwa R, Pancras G, Sirili N BMC Health Serv Res. 2025; 25(1):12.

PMID: 39754181 PMC: 11697796. DOI: 10.1186/s12913-024-12151-0.


Globalization of clinical trials in oncology: a worldwide quantitative analysis.

Izarn F, Henry J, Besle S, Ray-Coquard I, Blay J, Allignet B ESMO Open. 2024; 10(1):104086.

PMID: 39700605 PMC: 11728923. DOI: 10.1016/j.esmoop.2024.104086.


Challenges in institutional ethical review process and approval for international multicenter clinical studies in lower and middle-income countries: the case of PARITY study.

Lopez-Baron E, Abbas Q, Caporal P, Agulnik A, Attebery J, Holloway A Front Pediatr. 2024; 12:1460377.

PMID: 39568786 PMC: 11577162. DOI: 10.3389/fped.2024.1460377.


Reporting ethical approval in case reports and case series in 12 consecutive years: A systematic review.

Tran L, Thanh Huan V, Tai L, Safi A, Ahmed M, Algazar M Health Care Sci. 2024; 3(5):298-311.

PMID: 39479275 PMC: 11520241. DOI: 10.1002/hcs2.113.


References
1.
Check D, Weinfurt K, Dombeck C, Kramer J, Flynn K . Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature. Clin Trials. 2013; 10(4):560-7. DOI: 10.1177/1740774513484393. View

2.
Lidz C, Appelbaum P, Arnold R, Candilis P, Gardner W, Myers S . How closely do institutional review boards follow the common rule?. Acad Med. 2012; 87(7):969-74. PMC: 3386463. DOI: 10.1097/ACM.0b013e3182575e2e. View

3.
Coleman C, Bouesseau M . How do we know that research ethics committees are really working? The neglected role of outcomes assessment in research ethics review. BMC Med Ethics. 2008; 9:6. PMC: 2324094. DOI: 10.1186/1472-6939-9-6. View

4.
Weil C, Rooney L, McNeilly P, Cooper K, Borror K, Andreason P . OHRP compliance oversight letters: an update. IRB. 2010; 32(2):1-6. View

5.
Emanuel E, Menikoff J . Reforming the regulations governing research with human subjects. N Engl J Med. 2011; 365(12):1145-50. DOI: 10.1056/NEJMsb1106942. View